Deutsche Studiengruppe Multiples Myelom Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2011
NCT01208766
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Deutsche Studiengruppe Multiples Myelom (DSMM) | DSMM (Deutsche Studiengruppe Multiples Myelom)